Metastatic Uveal Melanoma Completed Phase 2 Trials for Sunitinib (DB01268)

Also known as: Metastatic Malignant Uveal Melanoma / Metastatic Uveal Melanoma (UM) / Uveal Melanoma, Metastatic / Melanoma, Uveal Metastatic

IndicationStatusPhase
DBCOND0051900 (Metastatic Uveal Melanoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01551459A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal MelanomaTreatment